JAG1 and polycystic ovary syndrome: In a recent study involving women with endometrial disorders including RIF, endometriosis, and PCOS, the expression pattern of NOTCH pathway molecules including NOTCH1, 3, JAG1, 2, and survivin in the mid-luteal phase were distinctly expressed in the patient groups compared to controls (43).